A Stanford researcher and two collaborators conducted an extensive review of Alcoholics Anonymous studies and found that the fellowship helps more people achieve sobriety than therapy does.

Researchers used electroencephalography and artificial intelligence to identify individuals who would likely respond to sertraline, the antidepressant marketed as Zoloft.

Protein levels in people’s blood can predict their age, a Stanford study has found. The study also found that aging isn’t a smoothly continuous process.

Transient bursts of high-frequency electrical activity in epileptic brain tissue can impair cognition even when no seizure is occurring, Stanford scientists have found.

A drug may help children with Pelizaeus-Merzbacher disease, a deadly neurological disorder, according to a study by researchers at Stanford, UCSF and Cambridge.

Jin Hyung Lee will receive $3.5 million to study the use of innovative technology to analyze brain circuitry, and Corey Keller will receive $1.25 million to fund work into brain stimulation treatments for mental illness.

In human cell cultures, countering a defect that appears to be nearly universal among patients with Parkinson’s disease prevents death in the cells whose loss causes the disease.

A Stanford research team has identified an oddball way brain cells spread inflammation in several neurodegenerative diseases — and an approach that could counter them all.

Researchers at Stanford and Trinity College in Dublin report preliminary evidence of damage to the brain’s protective barrier in adolescent and adult athletes even if they did not report a concussion.

Stanford researchers blocked a molecule to help restore neurons in rats in which the flow of fresh blood to the brain was reduced. The approach could lead to new treatments for people who have suffered a stroke or cardiac arrest.